Vanta Bioscience Ltd Half Yearly Results

Gross Sales

0.3

0.93

1.03

3.55

6.18

Excise Duty

0

0

0

0

0

Net Sales

0.3

0.93

1.03

3.55

6.18

Other Operating Income

0

0

0

0

0

Other Income

0

0.07

0.04

0.08

0.03

Total Income

0.3

1

1.07

3.62

6.21

Total Expenditure

0.67

4.81

1.41

4.3

4.11

PBIDT

-0.37

-3.8

-0.34

-0.68

2.09

Interest

0.88

1.92

2.14

2.9

2.85

PBDT

-1.25

-5.73

-2.49

-3.57

-0.76

Depreciation

0.61

2.73

1.69

2.95

1.54

Minority Interest Before NP

0

-6.45

-2.06

-4.55

-1.74

Tax

0

0

0

-0.04

0.04

Deferred Tax

-0.05

0.71

-0.05

-0.16

-0.06

Reported Profit After Tax

-1.82

-2.71

-2.07

-1.78

-0.54

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-1.82

-2.71

-2.07

-1.78

-0.54

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-1.82

-2.71

-2.07

-1.78

-0.54

EPS (Unit Curr.)

-2.56

-4.29

-3.28

-2.82

-0.85

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

7.11

6.31

6.31

6.31

6.31

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-123.33

-408.6

-33

-19.15

33.81

PBDTM(%)

-

-

-

-

-

PATM(%)

-606.66

-291.39

-200.97

-50.14

-8.73